Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12912631 [patent_doc_number] => 20180196053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => METHODS AND KITS FOR DETECTING CANCER [patent_app_type] => utility [patent_app_number] => 15/865727 [patent_app_country] => US [patent_app_date] => 2018-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865727 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/865727
METHODS AND KITS FOR DETECTING CANCER Jan 8, 2018 Abandoned
Array ( [id] => 13413269 [patent_doc_number] => 20180258177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-13 [patent_title] => ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/863526 [patent_app_country] => US [patent_app_date] => 2018-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863526 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/863526
Anti-human 4-1BB antibodies and uses thereof Jan 4, 2018 Issued
Array ( [id] => 12746599 [patent_doc_number] => 20180140700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-24 [patent_title] => COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR [patent_app_type] => utility [patent_app_number] => 15/849018 [patent_app_country] => US [patent_app_date] => 2017-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15849018 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/849018
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor Dec 19, 2017 Issued
Array ( [id] => 13586631 [patent_doc_number] => 20180344864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR [patent_app_type] => utility [patent_app_number] => 15/846083 [patent_app_country] => US [patent_app_date] => 2017-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15846083 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/846083
COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR Dec 17, 2017 Abandoned
Array ( [id] => 12842548 [patent_doc_number] => 20180172689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-21 [patent_title] => METHODS FOR DIAGNOSIS OF BLADDER CANCER [patent_app_type] => utility [patent_app_number] => 15/844828 [patent_app_country] => US [patent_app_date] => 2017-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25172 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844828 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/844828
METHODS FOR DIAGNOSIS OF BLADDER CANCER Dec 17, 2017 Abandoned
Array ( [id] => 16337547 [patent_doc_number] => 10788496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => MEK1 mutation conferring resistance to RAF and MEK inhibitors [patent_app_type] => utility [patent_app_number] => 15/844236 [patent_app_country] => US [patent_app_date] => 2017-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 28093 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844236 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/844236
MEK1 mutation conferring resistance to RAF and MEK inhibitors Dec 14, 2017 Issued
Array ( [id] => 13590097 [patent_doc_number] => 20180346597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2 [patent_app_type] => utility [patent_app_number] => 15/839391 [patent_app_country] => US [patent_app_date] => 2017-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15839391 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/839391
Human monoclonal antibodies to ganglioside GD2 Dec 11, 2017 Issued
Array ( [id] => 17280877 [patent_doc_number] => 11197890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-14 [patent_title] => Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines [patent_app_type] => utility [patent_app_number] => 15/839105 [patent_app_country] => US [patent_app_date] => 2017-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 1 [patent_no_of_words] => 24841 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15839105 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/839105
Methods of treating cancer, infectious disease, and autoimmune disease using CXC chemokines Dec 11, 2017 Issued
Array ( [id] => 12766375 [patent_doc_number] => 20180147293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => ANTIGEN BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 15/828770 [patent_app_country] => US [patent_app_date] => 2017-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15828770 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/828770
ANTIGEN BINDING PROTEINS Nov 30, 2017 Abandoned
Array ( [id] => 12880987 [patent_doc_number] => 20180185504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => METHODS OF TREATING PRLR POSITIVE BREAST CANCER [patent_app_type] => utility [patent_app_number] => 15/824546 [patent_app_country] => US [patent_app_date] => 2017-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824546 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/824546
Methods of treating PRLR positive breast cancer Nov 27, 2017 Issued
Array ( [id] => 17571120 [patent_doc_number] => 11319378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-03 [patent_title] => Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing the same [patent_app_type] => utility [patent_app_number] => 16/461646 [patent_app_country] => US [patent_app_date] => 2017-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 10569 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 457 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461646 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/461646
Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing the same Nov 15, 2017 Issued
Array ( [id] => 12912634 [patent_doc_number] => 20180196054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => BIOMARKERS FOR OVARIAN CANCER CTAP3-RELATED PROTEINS [patent_app_type] => utility [patent_app_number] => 15/809591 [patent_app_country] => US [patent_app_date] => 2017-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809591 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/809591
Biomarkers for ovarian cancer CTAP3-related proteins Nov 9, 2017 Issued
Array ( [id] => 12685462 [patent_doc_number] => 20180120320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => NOVEL METHOD FOR ANALYZING CIRCULATING TUMOR CELLS OF A PATIENT FOR THE PRESENCE OF METASTASIS-INITIATING CELLS [patent_app_type] => utility [patent_app_number] => 15/796647 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8892 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796647 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/796647
NOVEL METHOD FOR ANALYZING CIRCULATING TUMOR CELLS OF A PATIENT FOR THE PRESENCE OF METASTASIS-INITIATING CELLS Oct 26, 2017 Abandoned
Array ( [id] => 14007849 [patent_doc_number] => 10222376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-05 [patent_title] => Methods and compositions for identifying leukemic stem cells [patent_app_type] => utility [patent_app_number] => 15/796201 [patent_app_country] => US [patent_app_date] => 2017-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12502 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 270 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796201 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/796201
Methods and compositions for identifying leukemic stem cells Oct 26, 2017 Issued
Array ( [id] => 14210651 [patent_doc_number] => 20190117710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-25 [patent_title] => METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF CHECKPOINT PROTEINS [patent_app_type] => utility [patent_app_number] => 15/789266 [patent_app_country] => US [patent_app_date] => 2017-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15789266 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/789266
METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF CHECKPOINT PROTEINS Oct 19, 2017 Abandoned
Array ( [id] => 16322343 [patent_doc_number] => 10782302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-22 [patent_title] => Detectors of serum biomarkers for predicting ovarian cancer recurrence [patent_app_type] => utility [patent_app_number] => 15/785898 [patent_app_country] => US [patent_app_date] => 2017-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 32 [patent_no_of_words] => 22977 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15785898 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/785898
Detectors of serum biomarkers for predicting ovarian cancer recurrence Oct 16, 2017 Issued
Array ( [id] => 12624555 [patent_doc_number] => 20180100015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET [patent_app_type] => utility [patent_app_number] => 15/719750 [patent_app_country] => US [patent_app_date] => 2017-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15719750 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/719750
COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET Sep 28, 2017 Abandoned
Array ( [id] => 16549769 [patent_doc_number] => 10882918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Bispecific T cell activating antigen binding molecules [patent_app_type] => utility [patent_app_number] => 15/718818 [patent_app_country] => US [patent_app_date] => 2017-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 20 [patent_no_of_words] => 50092 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15718818 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/718818
Bispecific T cell activating antigen binding molecules Sep 27, 2017 Issued
Array ( [id] => 17268517 [patent_doc_number] => 11193937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-07 [patent_title] => Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue [patent_app_type] => utility [patent_app_number] => 15/712246 [patent_app_country] => US [patent_app_date] => 2017-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 15040 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 376 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712246 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/712246
Immunohistochemical assay for detecting expression of programmed death ligand 1 (PD-L1) in tumor tissue Sep 21, 2017 Issued
Array ( [id] => 18765120 [patent_doc_number] => 11815516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Protein biomarkers for diseases associated with the contact activation system [patent_app_type] => utility [patent_app_number] => 16/333155 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 16470 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333155 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/333155
Protein biomarkers for diseases associated with the contact activation system Sep 14, 2017 Issued
Menu